SYBX Synlogic, Inc. Stock Quote

SYBX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.64	Insider Own	18.88%	Shs Outstand	36.30M	Perf Week	-1.24%
Market Cap	156.53M	Forward P/E	-	EPS next Y	-1.56	Insider Trans	0.00%	Shs Float	32.76M	Perf Month	7.55%
Income	-57.40M	PEG	-	EPS next Q	-0.41	Inst Own	37.20%	Short Float	1.40%	Perf Quarter	59.60%
Sales	1.80M	P/S	86.96	EPS this Y	16.40%	Inst Trans	5.45%	Short Ratio	0.30	Perf Half Y	81.36%
Book/sh	3.32	P/B	1.20	EPS next Y	6.60%	ROA	-34.40%	Target Price	-	Perf Year	83.87%
Cash/sh	2.60	P/C	1.53	EPS next 5Y	-	ROE	-41.60%	52W Range	1.35 - 5.11	Perf YTD	84.72%
Dividend	-	P/FCF	-	EPS past 5Y	23.60%	ROI	-34.60%	52W High	-21.92%	Beta	1.98
Dividend %	-	Quick Ratio	16.40	Sales past 5Y	-	Gross Margin	-	52W Low	195.56%	ATR	0.39
Employees	76	Current Ratio	16.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	48.77	Volatility	8.35% 9.69%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	6.20%	Profit Margin	-	Rel Volume	0.17	Prev Close	3.80
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.54M	Price	3.99
Recom	1.70	SMA20	-8.92%	SMA50	15.07%	SMA200	59.74%	Volume	265,832	Change	5.00%

Aug-21-19

Downgrade

Oppenheimer

Outperform → Perform

Apr-30-19

Initiated

Jefferies

Buy

$18

Dec-13-18

Initiated

Chardan Capital Markets

Buy

$20

Mar-19-18

Initiated

H.C. Wainwright

Buy

$20

Jan-29-18

Initiated

Piper Jaffray

Overweight

$16

Feb-15-21 07:00AM	Synlogic to Present at Upcoming Virtual Banking and Industry Conferences PR Newswire
Feb-10-21 07:00AM	Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors PR Newswire
Feb-02-21 06:30AM	Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory PR Newswire
Jan-14-21 08:56AM	Do Options Traders Know Something About Synlogic (SYBX) Stock We Don't? Zacks
05:28AM	What Type Of Shareholders Make Up Synlogic, Inc.'s (NASDAQ:SYBX) Share Registry? Simply Wall St.
Jan-11-21 06:30AM	Synlogic Outlines Upcoming Clinical Milestones PR Newswire
Dec-14-20 11:41AM	Synlogic Announces Progress on Lymphoma Drug TheStreet.com +13.39%
06:00AM	Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma PR Newswire
Dec-09-20 06:30AM	Synlogic Appoints Michael Heffernan to its Board of Directors PR Newswire
Dec-07-20 12:27PM	Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering PR Newswire
Dec-02-20 10:47PM	Is Synlogic (SYBX) A Good Stock To Buy Now? Insider Monkey +6.96%
Nov-27-20 08:47AM	Synlogic (SYBX) Catches Eye: Stock Jumps 12.9% Zacks
Nov-18-20 06:30AM	Synlogic to Present at Upcoming Virtual Banking Conference PR Newswire
Nov-09-20 10:04AM	Earnings Beat: Synlogic, Inc. (NASDAQ:SYBX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Simply Wall St.
Nov-05-20 08:42AM	Recap: Synlogic Q3 Earnings Benzinga +6.38%
07:54AM	The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga
06:30AM	Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update PR Newswire
Nov-04-20 04:05PM	Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria PR Newswire
Oct-27-20 06:30AM	Synlogic Announces Third Quarter 2020 Conference Call & Webcast PR Newswire
Oct-22-20 06:30AM	Synlogic Presents Preclinical Data on SYNB8802 for Enteric Hyperoxaluria at American Society of Nephrology (ASN) Kidney Week 2020 PR Newswire
Sep-14-20 07:00AM	Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer PR Newswire +5.71%
Sep-10-20 02:15PM	We're Keeping An Eye On Synlogic's (NASDAQ:SYBX) Cash Burn Rate Simply Wall St.
Sep-08-20 11:46AM	Synlogic to Present at Upcoming Virtual Banking Conferences PR Newswire
Aug-28-20 09:37AM	7 Top Stocks Under $5 InvestorPlace
Aug-24-20 03:30PM	2 Healthcare Stocks Under $5 That Could Deliver Triple-Digit Gains TipRanks +6.76%
Aug-06-20 07:00AM	Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update PR Newswire -6.87%
Jul-31-20 02:49PM	Synlogic to Present at Upcoming Virtual Banking Conferences PR Newswire
Jul-30-20 07:00AM	Synlogic Announces Promotion of Antoine 'Tony' Awad to Chief Operating Officer and Additions to Leadership Team PR Newswire
Jul-28-20 07:30AM	Synlogic Announces Second Quarter 2020 Conference Call & Webcast PR Newswire
Jun-17-20 09:38PM	Edited Transcript of SYBX.OQ earnings conference call or presentation 8-May-20 12:00pm GMT Thomson Reuters StreetEvents
Jun-12-20 11:19AM	Is Synlogic, Inc. (SYBX) A Good Stock To Buy? Insider Monkey +7.43%
Jun-01-20 05:46AM	Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors PR Newswire
May-27-20 08:00AM	Synlogic Hosts First Virtual R&D Event PR Newswire
May-21-20 04:02PM	Synlogic to Host Virtual R&D Event PR Newswire -7.82%
08:01AM	The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive Benzinga
06:00AM	Synlogic Announces Termination of AbbVie Collaboration Agreement PR Newswire
May-08-20 07:44AM	Recap: Synlogic Q1 Earnings Benzinga
06:00AM	Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update PR Newswire
May-04-20 04:02PM	Synlogic Announces First Quarter 2020 Conference Call and Webcast PR Newswire +8.87%
Apr-01-20 07:32AM	Edited Transcript of SYBX earnings conference call or presentation 12-Mar-20 9:00pm GMT Thomson Reuters StreetEvents
Mar-30-20 06:00AM	Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational Activities PR Newswire
Mar-15-20 11:00AM	Synlogic, Inc. Analysts Are Cutting Their Estimates: Here's What You Need To Know Simply Wall St.
Mar-12-20 04:19PM	Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update PR Newswire -9.74%
03:00PM	Synlogic, Inc. to Host Earnings Call ACCESSWIRE
Mar-11-20 04:02PM	Synlogic to Present at Chardan's Virtual Microbiome Medicines Summit PR Newswire -9.41%
Mar-05-20 04:02PM	Synlogic Announces Fourth Quarter and Full Year 2019 Conference Call and Webcast PR Newswire
Feb-19-20 02:04PM	Some Synlogic (NASDAQ:SYBX) Shareholders Have Taken A Painful 73% Share Price Drop Simply Wall St.
Feb-18-20 04:02PM	Synlogic Announces Participation in Upcoming Investor Conferences PR Newswire +5.83%
Jan-24-20 08:01AM	Will Synlogic Continue to Surge Higher? Zacks
Jan-14-20 08:33AM	BioMarin to Begin Early-Stage Study on Gene Therapy for PKU Zacks +6.23%
Jan-09-20 06:00AM	Synlogic Outlines Upcoming Milestones for Clinical Programs and Unveils New Preclinical Pipeline Programs Business Wire +5.54%
Jan-06-20 09:20AM	Can The Uptrend Continue for Synlogic? Zacks
Dec-20-19 03:29PM	Here is What Hedge Funds Think About Synlogic, Inc. (SYBX) Insider Monkey
Dec-12-19 07:55AM	Will Synlogic Continue to Surge Higher? Zacks
Dec-11-19 06:00AM	Synlogic Bridging Study Data with Solid Oral Formulation of SYNB1618, a Synthetic Biotic Approach to Treat Phenylketonuria, Demonstrate Improved Tolerability over Early Liquid Formulation and Guide to Next Stage of Clinical Development Business Wire
Dec-10-19 07:00AM	Biotech accelerator teams with investment firm for $210M fund raise American City Business Journals +10.93%
Dec-05-19 02:37PM	Edited Transcript of SYBX earnings conference call or presentation 12-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-25-19 04:02PM	Synlogic to Webcast Presentation at the Piper Jaffray 31st Annual Healthcare Conference TEST Business Wire Releases
04:02PM	Synlogic to Webcast Presentation at the Piper Jaffray 31st Annual Healthcare Conference Business Wire
Nov-14-19 11:41AM	Can Synlogic (NASDAQ:SYBX) Afford To Invest In Growth? Simply Wall St.
Nov-12-19 04:02PM	Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results Business Wire
Nov-07-19 03:07PM	Synlogic, Inc. (SYBX) Is Burning These Hedge Funds Insider Monkey
Nov-05-19 04:02PM	Synlogic Announces Third Quarter 2019 Conference Call and Webcast Business Wire
Sep-30-19 04:02PM	Synlogic to Present at the Chardan 3rd Annual Genetic Medicines Conference Business Wire +8.02%
Sep-26-19 07:00AM	Sherlock Bio gets DoD grant to bring CRISPR to the battlefield American City Business Journals -7.76%
Sep-25-19 05:23PM	Edited Transcript of SYBX earnings conference call or presentation 8-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Sep-12-19 12:56PM	Those Who Purchased Synlogic (NASDAQ:SYBX) Shares A Year Ago Have A 78% Loss To Show For It Simply Wall St.
Sep-06-19 03:46PM	Synlogic Announces Appointments of New CMO, Head of Regulatory Affairs, and CFO Departure Business Wire -8.53%
Sep-05-19 08:12AM	The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug Benzinga
Sep-04-19 04:01PM	Synlogic Announces Appointments of New CMO, Head of Regulatory Affairs, and CFO Departure Business Wire -8.49%
06:00AM	Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM) Business Wire
Aug-24-19 01:46PM	10 Biopharmaceutical Companies Trying To Cure Cancer Benzinga
Aug-21-19 06:03PM	Synlogic Discontinues Development of SYNB1020, Stock Down Zacks -7.45%
Aug-20-19 07:38AM	Synlogic's stock sinks toward record low after SYNB1020 development discontinued as trial disappoints MarketWatch -27.74%
07:33AM	The Daily Biotech Pulse: FDA Likes Nabriva's Antibiotic, Snubs Sarepta's DMD Drug; Moderna Gets Fast Track Designation For Zika Vaccine Benzinga
06:00AM	Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia Business Wire
Aug-08-19 05:00PM	Synlogic to Present at the 2019 Wedbush PacGrow Healthcare Conference Business Wire +5.26%
04:02PM	Synlogic Reports Second Quarter 2019 Financial Results and Provides Program Updates Business Wire
06:38AM	Microbiome biotechs grapple with how to protect their IP American City Business Journals
Aug-01-19 04:02PM	Synlogic Announces Second Quarter 2019 Conference Call and Webcast Business Wire -7.84%
Jul-25-19 09:54AM	Synlogic Enters Oversold Territory Zacks
Jul-15-19 06:00AM	Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development Business Wire
Jul-01-19 01:10PM	American Gene Technologies: The Software Revolution for the Next 100 Years Zacks Small Cap Research
Jun-12-19 06:30AM	Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic Medicines Business Wire +25.20%
May-23-19 04:15PM	Synlogic (SYBX) Enters Cancer Collaboration with Roche Zacks
May-22-19 07:00AM	Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors Business Wire
May-16-19 09:14PM	Synlogic, Inc. (SYBX) Q1 2019 Earnings Call Transcript Motley Fool
May-15-19 01:12PM	Edited Transcript of SYBX earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-09-19 04:02PM	Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire
May-02-19 04:05PM	Synlogic Announces First Quarter 2019 Conference Call and Webcast Business Wire -8.12%
Apr-30-19 07:00AM	Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic Medicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) Business Wire +10.85%
Apr-26-19 04:26PM	Gut Check: The Bacteria In Your Intestines Could Help Cure Cancer Investor's Business Daily
11:43AM	Could Synlogic, Inc.'s (NASDAQ:SYBX) Investor Composition Influence The Stock Price? Simply Wall St.
Apr-15-19 04:10PM	Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) Business Wire
Apr-09-19 07:00AM	Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer Business Wire
Apr-02-19 04:05PM	Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference Business Wire
Mar-18-19 11:41AM	Edited Transcript of SYBX earnings conference call or presentation 12-Mar-19 12:00pm GMT Thomson Reuters StreetEvents
Mar-13-19 04:05PM	Synlogic to Webcast Presentation at the Oppenheimer 29th Annual Healthcare Conference Business Wire
Mar-12-19 07:00AM	Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update Business Wire -7.86%
Mar-06-19 07:00AM	Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic Medicines to Treat Inflammatory Bowel Disease Business Wire -6.87%

Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase I/IIa clinical trial to treat phenylketonuria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience